Pharma stock falls over 4% after company announces mixed Q1 results
Trade Brains
AUGUST 7, 2025
Synopsis: Namita Thapar-backed Emcure Pharmaceuticals Ltd reported a resilient Q1FY26 performance, with net profit rising 9.1 Emcure Pharmaceuticals Ltd , with a market cap of Rs. We continue to augment our portfolio in all our focus markets though in-licensing and in-house development. percent QoQ and 40.5
Let's personalize your content